The Analysis of E-Cadherin, N-Cadherin, Vimentin, HER-2, CEA, CA15-3 and SF Expression in the Diagnosis of Canine Mammary Tumors
Open Access
Abstract
Canine mammary tumors (CMTs) are one of the most common tumors in female dogs, and they are associated with a poor prognosis owing to their high rate of recurrence and metastasis rates, which make their diagnosis especially important in clinical veterinary medicine. In this study, the characteristics of tumors were observed in dogs suffering from CMTs, and clinical diagnosis and histopathology were used to identify tumors. Furthermore, the expression levels of tumor markers for CMTs were analyzed by enzyme-linked immunosorbent assay (ELISA) and quantitative PCR (qPCR). Upon clinical examination, dogs with CMTs displayed a distinct and irregular mass in the mammary gland, and X-ray (Latero-lateral and ventro-dorsal views) and ultrasonography of the abdomen revealed a moderately echogenic mass at the mammary gland with slightly stronger density than the surrounding tissue. A total of 30 tumors were identified by histopathology, 11 benign and 19 malignant. Changes in some indicators in dogs suffering from CMTs and healthy dogs suggested that there were multiple direct or paraneoplastic changes associated with tumors that could be detected/suspected by hematological examination, and ELISA revealed the HER-2 serum concentrations were significantly different between healthy animals and those with malignant tumors. qPCR indicated that tumor markers N-cadherin, Vimentin, HER-2, CEA, CA15-3 and SF were higher in dogs with malignant tumors than healthy dogs, with a low level of E-cadherin in malignant tumors. This study verified that serological tests and molecular biological tests were essential to the early diagnosis, treatment and prognosis of dogs with tumors.Keywords
Funding Information
- National Natural Science Foundation of China (32273075, 31672616)
- National Key R&D Program of China (2016YFD0501000)
This publication has 41 references indexed in Scilit:
- Identification of prognostic factors in canine mammary malignant tumours: a multivariable survival studyBMC Veterinary Research, 2013
- Prognostic Value of Histological Grading in Noninflammatory Canine Mammary Carcinomas in a Prospective Study With Two-Year Follow-UpVeterinary Pathology, 2012
- Expression of HER-2 and nuclear localization of HER-3 protein in canine mammary tumors: Histopathological and immunohistochemical studyThe Veterinary Journal, 2011
- Classification and Grading of Canine Mammary TumorsVeterinary Pathology, 2011
- The ELISA, Enzyme-Linked Immunosorbent AssayClinical Chemistry, 2010
- CRP identifies homeostatic immune oscillations in cancer patients: a potential treatment targeting tool?Journal of Translational Medicine, 2009
- The relationship between tumour size and expression of prognostic markers in benign and malignant canine mammary tumoursVeterinary and Comparative Oncology, 2009
- Evaluation of serum haptoglobin and C‐reactive protein in dogs with mammary tumorsVeterinary Clinical Pathology, 2009
- Influence of Host Factors on Survival in Dogs with Malignant Mammary Gland TumorsJournal of Veterinary Internal Medicine, 2003
- Influence of Host Factors on Survival in Dogs with Malignant Mammary Gland TumorsJournal of Veterinary Internal Medicine, 2003